Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 5, 2012, Pages 1756-1763

  Pai Panandiker, Atmaram S ^a   Merchant, Thomas E ^a   Beltran, Chris ^a   Wu, Shengjie ^a   Sharma, Shelly ^a   Boop, Frederick A ^a   Jenkins, Jesse J ^a   Helton, Kathleen J ^a   Wright, Karen D ^a   Broniscer, Alberto ^a   Kun, Larry E ^a   Gajjar, Amar ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Atypical teratoid rhabdoid tumor; Local failure; Pattern of failure; Radiation therapy; Therapeutic sequencing

Indexed keywords

CENTRAL NERVOUS SYSTEMS; CRANIOSPINAL IRRADIATION; CUMULATIVE INCIDENCE; CURRENT TREATMENTS; DISEASE PROGRESSION; DISTANT METASTASIS; HAZARD RATIO; HIGH DOSE; LOCAL FAILURE; LOCAL THERAPY; LOCALIZED TUMORS; METASTATIC DISEASE; OVERALL SURVIVAL; PEDIATRIC PATIENTS; PROGRESSION FREE SURVIVAL; SURGICAL RESECTION; THERAPEUTIC PARADIGMS; THERAPEUTIC SEQUENCING; TREATMENT FAILURE; TUMOR BED; TUMOR LOCATION;

CHEMOTHERAPY; IRRADIATION; PATHOLOGY; PEDIATRICS; RADIOTHERAPY; SURGERY; TUMORS;

DIAGNOSIS;

ADOLESCENT; AGE; ARTICLE; ATYPICAL TERATOID RHABDOID TUMOR; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFANT; LOCAL THERAPY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RETROSPECTIVE STUDY; RHABDOID TUMOR; RISK ASSESSMENT; SCHOOL CHILD; SEX; TERATOMA; THERAPY DELAY; TREATMENT FAILURE;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; MALE; POSTOPERATIVE CARE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RHABDOID TUMOR; RISK ASSESSMENT; TIME FACTORS; TREATMENT FAILURE;

EID: 84858706658     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.02.059     Document Type: Article

References (30)

1. Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998;394: 203-206. (Pubitemid 28325977)
2. Biegel JA, Zhou JY, Rorke LB, et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999;59:74-79. (Pubitemid 29062960)
3. Biegel JA, Kalpana G, Knudsen ES, et al. The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: Meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors. Cancer Res 2002;62:323-328. (Pubitemid 34074022)
4. Packer RJ, Biegel JA, Blaney S, et al. Atypical teratoid/rhabdoid tumor of the central nervous system: Report on workshop. J Pediatr Hematol Oncol 2002;24:337-342. (Pubitemid 34774002)
5. Chen YW, Wong TT, Ho DM, et al. Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience). Int J Radiat Oncol Biol Phys 2006;64:1038-1043.
6. Chi SN, Zimmerman MA, Yao X, et al. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 2009;27:385-389.
7. Tekautz TM, Fuller CE, Blaney S, et al. Atypical teratoid/rhabdoid tumors (ATRT): Improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 2005;23:1491-1499.
8. National Cancer Institute, National Institutes of Health: Phase III pilot study of induction chemotherapy followed by consolidation myeloablative chemotherapy comprising thiotepa and carboplatin with or without etoposide and autologous hematopoietic stem cell rescue in pediatric patients with previously untreatedmalignant brain tumors. http://www.cancer.gov/clinical trials/search/view?cdrid=503990&version=HealthProfessional &protocolsearchid=9119921. Accessed May 6, 2011.
9. National Cancer Institute, National Institutes of Health: Treatment of atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system with surgery, intensive chemotherapy, and 3-D conformal radiation. http://www.cancer.gov/clinicaltrials/ COG-ACNS0333. Accessed May 6, 2011.
10. National Cancer Institute, National Institutes of Health: Risk-adapted therapy for children less than 3 years of age with embryonal brain tumors, choroid plexus carcinoma or ependymoma. http://www.cancer.gov/clinicaltrials/ search/view? cdrid=652289&version=HealthProfessional&protocolsearchid= 9119900. Accessed May 6, 2011.
11. Roberts CW, Biegel JA. The role of SMARCB1/INI1 in development of rhabdoid tumor. Cancer Biol Ther 2009;8:412-416.
12. Biegel JA, Rorke LB, Packer RJ, et al. Monosomy 22 in rhabdoid or atypical tumors of the brain. J Neurosurg 1990;73:710-714. (Pubitemid 20364485)
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
14. Cox DR. Regression models and lifetables. J R Stat Soc[B] 1972;34:187-220.
15. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of competing risk. Ann Stat 1988;16:1140-1154.
16. Fine JP, Gray RJ.A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
17. Burger PC, Yu IT, Tihan T, et al. Atypical teratoid/rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: A Pediatric Oncology Group study. Am J Surg Pathol 1998;22:1083-1092. (Pubitemid 28411066)
18. Cheng YC, Lirng JF, Chang FC, et al. Neuroradiological findings in atypical teratoid/rhabdoid tumor of the central nervous system. Acta Radiol 2005;46:89-96.
19. Rorke LB, Packer RJ, Biegel JA. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: Definition of an entity. J Neurosurg 1996;85:56-65. (Pubitemid 26195038)
20. National Cancer Institute, National Institutes of Health: Treatment of patients with newly diagnosed medulloblastoma, supratentorial primitive neuroectodermal tumor, or atypical teratoid rhabdoid tumor. http://www.cancer. gov/clinicaltrials/search/ view?cdrid=652285&version= HealthProfessional&protocol searchid=7578779. Accessed May 6, 2011.
21. Gajjar A, Chintagumpala M, Ashley D, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial. Lancet Oncol 2006;7: 813-820. (Pubitemid 44464063)
22. Fouladi M, Chintagumpala M, Laningham FH, et al. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol 2004;22:4551-4560. (Pubitemid 41185122)
23. Fouladi M, Gilger E, Kocak M, et al. Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. J Clin Oncol 2005;23:7152-7160.
24. Mulhern RK, Merchant TE, Gajjar A, et al. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004;5:399-408. (Pubitemid 38878043)
25. Mulhern RK, Palmer SL, Merchant TE, et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 2005;23:5511-5519.
26. Merchant TE, Li C, Xiong X, et al. Conformal radiotherapy after surgery for paediatric ependymoma: A prospective study. Lancet Oncol 2009;10:258-266.
27. Morris EB, Li C, Khan RB, et al. Evolution of neurological impairment in pediatric infratentorial ependymoma patients. J Neurooncol 2009;94:391-398.
28. Di Pinto M, Conklin HM, Li C, et al. Investigating verbal and visual auditory learning after conformal radiation therapy for childhood ependymoma. Int J Radiat Oncol Biol Phys 2010; 77:1002-1008.
29. Merchant TE, Hua CH, Shukla H, et al. Proton versus photon radiotherapy for common pediatric brain tumors: Comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer 2008;51:110-117. (Pubitemid 351717400)
30. Bishop AJ, McDonald MW, Chang AL, et al. Infant brain tumors: incidence, survival, and the role of radiation based on surveillance, epidemiology, and end results (SEER) data. Int J Radiat Oncol Biol Phys 2010. In press.